Search Results - "Finetti, Pascal"

Deciphering Folate Receptor alphaGene Expression and mRNA Signatures in Ovarian Cancer: Implications for Precision Therapies.

Authors: Kfoury, Maria Finetti, Pascal Mamessier, Emilie et al.

Source: International Journal of Molecular Sciences. Nov2024, Vol. 25 Issue 22, p11953. 13p.

Immunologic constant of rejection as a predictive biomarker of immune checkpoint inhibitors efficacy in non-small cell lung cancer.

Authors: Mogenet, Alice Finetti, Pascal Denicolai, Emilie et al.

Source: Journal of Translational Medicine. 9/19/2023, Vol. 21 Issue 1, p1-11. 11p.

Prognostic and Predictive Value of LIV1 Expression in Early Breast Cancer and by Molecular Subtype.

Authors: de Nonneville, Alexandre Finetti, Pascal Boudin, Laurys et al.

Source: Pharmaceutics. Mar2023, Vol. 15 Issue 3, p938. 15p.

WEE1 Dependency and Pejorative Prognostic Value in Triple‐Negative Breast Cancer.

Authors: de Nonneville, Alexandre Finetti, Pascal Birnbaum, Daniel et al.

Source: Advanced Science. 9/8/2021, Vol. 8 Issue 17, p1-3. 3p.

A benchmarking study of individual somatic variant callers and voting-based ensembles for whole-exome sequencing.

Authors: Guille, Arnaud Adélaïde, José Finetti, Pascal et al.

Source: Briefings in Bioinformatics; Jan2025, Vol. 26 Issue 1, p1-11, 11p

An antisense oligonucleotide targeting the heat‐shock protein HSPB5 as an innovative therapeutic approach in pulmonary fibrosis.

Authors: Boutanquoi, Pierre‐Marie Pommerolle, Lenny Dondaine, Lucile et al.

Source: British Journal of Pharmacology. Jun2025, Vol. 182 Issue 12, p2713-2729. 17p.

Macrophages reprogramming driven by cancer-associated fibroblasts under FOLFIRINOX treatment correlates with shorter survival in pancreatic cancer.

Authors: Hussain, Zainab Bertran, Thomas Finetti, Pascal et al.

Source: Cell Communication & Signaling. 1/2/2024, Vol. 22 Issue 1, p1-17. 17p.

Inflammatory breast cancer in 210 patients: A retrospective study on epidemiological, anatomo-clinical features and therapeutic results.

Authors: Manai, Maroua Finetti, Pascal Mejri, Nesrine et al.

Source: Molecular & Clinical Oncology. Feb2019, Vol. 10 Issue 2, p223-230. 8p.

Validation and comparison of the molecular classifications of pancreatic carcinomas.

Authors: Birnbaum, David J. Finetti, Pascal Birnbaum, Daniel et al.

Source: Molecular Cancer. 11/6/2017, Vol. 16, p1-7. 7p. 1 Diagram, 1 Chart, 1 Graph.

CSPG4 expression in soft tissue sarcomas is associated with poor prognosis and low cytotoxic immune response.

Authors: Boudin, Laurys de Nonneville, A Finetti, Pascal et al.

Source: Journal of Translational Medicine. 10/11/2022, Vol. 20 Issue 1, p1-13. 13p.

MARCKS as a Potential Therapeutic Target in Inflammatory Breast Cancer.

Authors: Manai, Maroua ELBini-Dhouib, Ines Finetti, Pascal et al.

Source: Cells (2073-4409). Sep2022, Vol. 11 Issue 18, pN.PAG-N.PAG. 20p.

Whole-exome profiles of inflammatory breast cancer and pathological response to neoadjuvant chemotherapy.

Authors: Bertucci, François Guille, Arnaud Lerebours, Florence et al.

Source: Journal of Translational Medicine. 10/27/2024, Vol. 22 Issue 1, p1-15. 15p.

CISH Expression Is Associated with Metastasis-Free Interval in Triple-Negative Breast Cancer and Refines the Prognostic Value of PDL1 Expression.

Authors: Boudin, Laurys De Nonneville, Alexandre Finetti, Pascal et al.

Source: Cancers. Jul2022, Vol. 14 Issue 14, pN.PAG-N.PAG. 12p.

Down-Regulation of ECRG4, a Candidate Tumor Suppressor Gene, in Human Breast Cancer.

Authors: Sabatier, Renaud Finetti, Pascal Adelaide, José et al.

Source: PLoS ONE. 2011, Vol. 6 Issue 11, p1-8. 8p.

Molecular Profiles of Advanced Urological Cancers in the PERMED-01 Precision Medicine Clinical Trial.

Authors: Billon, Emilien Gravis, Gwenaelle Guille, Arnaud et al.

Source: Cancers. May2022, Vol. 14 Issue 9, pN.PAG-N.PAG. 14p.

ZNF703 mRNA-Targeting Antisense Oligonucleotide Blocks Cell Proliferation and Induces Apoptosis in Breast Cancer Cell Lines.

Authors: Udu-Ituma, Sandra Adélaïde, José Le, Thi Khanh et al.

Source: Pharmaceutics. Jul2023, Vol. 15 Issue 7, p1930. 17p.

Clinical, pathological, and comprehensive molecular analysis of the uterine clear cell carcinoma: a retrospective national study from TMRG and GINECO network.

Authors: Nigon, Elsa Lefeuvre-Plesse, Claudia Martinez, Alejandra et al.

Source: Journal of Translational Medicine. 6/23/2023, Vol. 21 Issue 1, p1-15. 15p.

CSPG4 Expression in GIST Is Associated with Better Prognosis and Strong Cytotoxic Immune Response.

Authors: de Nonneville, Alexandre Finetti, Pascal Picard, Maelle et al.

Source: Cancers. Mar2022, Vol. 14 Issue 5, p1306. 1p.

A 25-gene classifier predicts overall survival in resectable pancreatic cancer.

Authors: Birnbaum, David J. Finetti, Pascal Lopresti, Alexia et al.

Source: BMC Medicine. 9/20/2017, Vol. 15, p1-14. 14p. 5 Charts, 2 Graphs.

Prospective high-throughput genome profiling of advanced cancers: results of the PERMED-01 clinical trial.

Authors: Bertucci, François Gonçalves, Anthony Guille, Arnaud et al.

Source: Genome Medicine. 5/18/2021, Vol. 13 Issue 1, p1-20. 20p.